A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
Clinical trial NCT04603027 · COMPLETED
Trial details
- NCT number
- NCT04603027
- Sponsor
- Evelo Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2021-07-02
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.